(Q40780826)

English

A phase II study of ifosfamide in the treatment of relapses in Wilms' tumor

scientific article

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

23 September 2017

A phase II study of ifosfamide in the treatment of relapses in Wilms' tumor (English)

1 reference

stated in

Europe PubMed Central

23 September 2017

1 reference

Tournade MF

1

1 reference

stated in

Europe PubMed Central

23 September 2017

1 January 1989

1 reference

stated in

Europe PubMed Central

23 September 2017

Cancer Chemotherapy and Pharmacology

1 reference

stated in

Europe PubMed Central

23 September 2017

24 Suppl 1

1 reference

stated in

Europe PubMed Central

23 September 2017

S31-3

1 reference

stated in

Europe PubMed Central

23 September 2017

Effectiveness of preoperative chemotherapy in Wilms' tumor: results of an International Society of Paediatric Oncology (SIOP) clinical trial

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2547529

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ifosfamide--pharmacology, safety and therapeutic potential

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2547529

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mesnum as a protector against kidney and bladder toxicity with high-dose ifosfamide treatment

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2547529

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The treatment of Wilms' Tumor: Results of the second national Wilms' Tumor study

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2547529

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ifosfamide, mesna and vincristine in paediatric oncology

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2547529

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

PubMed ID

2547529

1 reference

stated in

Europe PubMed Central

PubMed ID

2547529

retrieved

23 September 2017

(Q40780826)

A phase II study of ifosfamide in the treatment of relapses in Wilms' tumor

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)